Phaseline

Targets › SLC39A8

SLC39A8 (Metal cation symporter ZIP8): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Other; next expected readout Dec 2027.

Electroneutral divalent metal cation:bicarbonate symporter of the plasma membrane mediating the cellular uptake of zinc and manganese, two divalent metal cations important for development, tissue homeostasis and immunity. Transports an electroneutral complex composed of a divalent metal cation and two bicarbonate anions or alternatively a bicarbonate and a selenite anion. (UniProt, Q9C0K1)

Open in Phaseline: the race on SLC39A8, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
National Institute on Alcohol Abuse and Alcoholism (NIAAA)Ethanol
ZIP8 ligand; substrate for metal ion transporter ZIP8 (SLC39A8)
SLC39A8Phase 1Healthy VolunteerDec 2027

Conditions

Healthy Volunteer (1)

Modalities

small molecule (1)

Companies

National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.